REFERENCES
- Anon. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41, 4–19.
- Belanger, F., Derouin, F., Grangeot-Keros, L. & Meyer, L. (1999). Incidence and risk factors for toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988–1995. Clinical Infectious Diseases, 28, 575–581.
- Bucher, H., Griffith, L., Guyatt, G. H. & Opravil, M. (1997). Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and Toxoplasma encephalitis in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 104–114.
- Canh, P., Belloso, W. H., Murillo, J. & Prada-Trujillo, G. (2000). AIDS in Latin America. Infectious Diseases Clinics of North America, 14, 185–209.
- Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Penny, R. & Cooper, D. A. (1992). Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Annals of Internal Medicine, 117, 106–111.
- Guimarães, A. C. S., Kawarabayashi, M., Borges, M. M., Tolezano, J. E. & Andrade Jr, H. F. (1993). Regional variation in toxoplasmosis seronegativity in the São Paulo metropolitan region. Revista do Instituto de Medicina Tropical de São Paulo, 35, 479–483.
- Kovacs, J. A. & Masur, H. (2000). Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. New England Journal of Medicine, 342, 1416–1429.
- Lanska, D. J. (1999). Epidemiology of human immunodeficiency virus infection and associated neurologic illness. Seminars in Neurology, 19, 105–111.
- Luft, B. J. & Remington, J. S. (1992). Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases, 15, 211–222.
- Podzamczer, D., Miró, J. M., Bolao, F., Gatell, J. M., Cosín, J., Sirera, G., Domingo, P., Laguna, F., Santamaría, J. & Verdejo, J. (1995). Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Annals of Internal Medicine, 123, 175–180.
- Ribera, E., Fernandez-Sola, A., Juste, C, Rovira, A., Romero, F. J., Armandans-Gil, L., Ruiz, I., Ocaña, I. & Pahissa, A. (1999). Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency-infected patients. Clinical Infectious Diseases, 29, 1461–1466.
- Richards Jr, F. O., Kovacs, J. A. & Luft, B. J. (1995). Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 21 (Suppl.1), S49–S56.
- Sackoff, J., McFarland, J., Su, S. & Bryan, E. (1998). Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 387–392.
- Selik, R. M., Starcher, E. T. & Curran, J. W. (1987). Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS, 1, 175–182.
- Szwarcwald, C. L., Bastos, F. I., Fonseca, M. G., Esteves, M. A. P. & Andrade, C. L. T. (2000). A disseminaç ão da epidemia de AIDS no Brasil, no período de 1987–1996: urna análise espacial. Cadernos de Saúde Pública, 16 (Suppl. 1), 7–19.